Compare TGS & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TGS | SHC |
|---|---|---|
| Founded | 1992 | 2015 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.4B |
| IPO Year | 2002 | 2020 |
| Metric | TGS | SHC |
|---|---|---|
| Price | $31.43 | $15.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $40.00 | $20.33 |
| AVG Volume (30 Days) | 388.4K | ★ 2.6M |
| Earning Date | 05-08-2026 | 05-01-2026 |
| Dividend Yield | ★ 2.99% | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $1,163,617,000.00 |
| Revenue This Year | $2.13 | $7.51 |
| Revenue Next Year | N/A | $6.00 |
| P/E Ratio | ★ $17.56 | $59.41 |
| Revenue Growth | N/A | ★ 5.74 |
| 52 Week Low | $19.74 | $10.17 |
| 52 Week High | $36.35 | $19.85 |
| Indicator | TGS | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 42.28 | 59.71 |
| Support Level | $28.08 | $15.19 |
| Resistance Level | $33.60 | $16.55 |
| Average True Range (ATR) | 1.46 | 0.42 |
| MACD | -0.48 | 0.27 |
| Stochastic Oscillator | 16.89 | 84.85 |
Transportadora de Gas del Sur SA is a transporters of natural gas in Latin America. The company's operating segments include Natural Gas Transportation, Midstream, Telecommunications, Production and Commercialization Liquids, Other Services, and Telecommunications. It generates maximum revenue from the Production and Commercialization of the Liquids segment. Geographically, it derives the majority of its revenue from Argentina.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.